| PUBLICATIONS! |
|
 | Hexafluoroacetone as Protecting and Activating Reagent:
New Routes to Amino, Hydroxy, and Mercapto Acids and Their Application for Peptide and Glyco- and Depsipeptide Modification
Jan Spengler, Christoph Böttcher, Fernando Albericio, and Klaus Burger; Chemical Reviews, 2006, Vol. 106, No. 11, 4728-4746. (.PDF/ ~775 kb)
|
| The concept of internal solubilization in peptide synthesis: ethylene glycol-based protecting groups
László Kocsis, Thomas Bruckdorfer, György Orosz; Tetrahedron Letters 49 (2008) 7015-7017.
In case you are interested in a copy, please send your request to: thomas.bruckdorfer@iris-biotech.de
|
| Shorter Arginine homologues to stabilize peptides towards tryptic digestion
Petra Henklein and Thomas Bruckdorfer; Chemistry Today, Vol. 26, Nr. 6, Nov-Dec 2008, 12-15. (.PDF/ ~292 kb)
|
| PEGylation – The Magic Wand – Turning Proteins and other Biopharmaceuticals into Super Performing Block Busters;
Thomas Bruckdorfer, PharManufacturing (2007) 34-41. (.PDF/ ~1,76 MB)
|
| Applications of Spermines and Polyamine Analogues:
Uncompetitive Antagonism of AMPA Receptors: Mechanistic Insights from Studies of Polyamine Toxin Derivatives.
T.F.Andersen, D.B.Tikhonov, U.Bolcho, K.Boshakov, J.K.Nelson, F.Pluteanu, I.R.Mellor, J.Egebjerg, K.Stromgaard.
Journal of Medicinal Chemistry 2006, Vol. 49, Nr. 18, 5414-5423 (.PDF/ ~579 kb)
|
| Press Release October 2004:
IRIS Biotech GmbH Launches New Sales Office in Brussels, Belgium
IRIS Biotech is pleased to announce the opening of a new sales office in Brussels, Belgium.
This office will support the growing demand for starting materials, for Peptide and DNA synthesis in
France and Benelux, where the company already has hundreds of customers. This new facility manifests
the position of IRIS Biotech in the market as a premium supplier and emphasizes their commitment to be close to their customers. (.PDF/ ~98 kb)
|
| Press Release May 2004:
IRIS Biotech acquired Patent from GBF for the production and marketing of new innovative linkers
IRIS Biotech has acquired several patents from GBF (Gesellschaft für Biotechnologische Forschung, Braunschweig Germany) for the production of new innovative linkers, designed and developed by Prof. Ronald Frank and his group; (.PDF/ ~108 kb)
|
| Easy Preparation of Synthetic Peptide Repertoires for Immunological Studies Utilizing SPOT Synthesis
Ronald Frank, Stefan Hoffmann, Heike Overwin, Christian Behn, and Heinrich Gausepohl; Peptides in Immunology, ed. By C.H. Schneider John Wiley & Sons Ltd. (1996) 197-204; (.PDF/ ~766 kb)
|
| From Production of Peptides in Milligram Amounts for Research to Multi-Tons Quantities for Drugs of the Future
Thomas Bruckdorfer, Oleg Marder and Fernando Albericio; Current Pharmaceutical Biotechnology, 2004, 5, 29-43; © 2004 Bentham Science Publishers Ltd.; (.PDF/ ~184 kb)
|
|
|
| IRIS Biotech GmbH, Waldershofer Str. 49-51, D-95615 Marktredwitz, Germany |
|
|